3rd Quarter - Report

JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$640,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Issues related to the regulation of cannabis and CBD Research and development of cannabis-derived therapies SAFE Banking Act 2023

LobbyistCovered position, as disclosed
MARK BOLTON —
KARAS GROSS —
VIRGINIA MCMILLIN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.